{"sourcedb":"DevicePMAs@therightstef","sourceid":"P030008_S003","text":"Approval for a change in repetition rate from 200 hz to 400 hz.  The device, as modified, will be marketed under the trade name allegretto wave eye-q excimer laser system and is indicated for laser assisted in situ keratomileusis (lasik) in patients who are 18 years of age or older:  1) for the reduction or elimination of myopia of up to -12.0 diopters (d) of sphere and up to -6.0 d of astigmatism at the spectacle plane in patients with documentation of a stable manifest refraction defined as \u003C=0.50 d of preoperative spherical equivalent shift over one year prior to surgery; and 2) for the reduction or elimination of hyperopic refractive errors up to +6.0 d of sphere with and without astigmatic refractive errors up to 5.0 d at the spectacle plane, with a maximum manifest refraction spherical equivalent (mrse) of +6.0 d in patients with documentation of a stable manifest refraction defined as \u003C=0.50 d of preoperative spherical equivalent shift over one year prior to surgery, exclusive of changes due to unmasking latent hyperopia.","project":"consensus_PMA_Age_Indications","denotations":[{"id":"T6","span":{"begin":277,"end":282},"obj":"age_end"},{"id":"T7","span":{"begin":261,"end":266},"obj":"age_start_unit"},{"id":"T8","span":{"begin":258,"end":260},"obj":"age_start"},{"id":"T3","span":{"begin":258,"end":282},"obj":"age_range"}]}